Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 2Carcinoma, Hepatocellular 2Rectal Diseases 1Pheochromocytoma 1Paraganglioma 1Pancreatic Neoplasms 1Neoplasms by Site 1Neoplasms 1Kidney Neoplasms 1Intestinal Neoplasms 1Intestinal Diseases 1Gastrointestinal Stromal Tumors 1Gastrointestinal Neoplasms 1Gastrointestinal Diseases 1Gallbladder Neoplasms 1Digestive System Neoplasms 1Digestive System Diseases 1Colonic Diseases 1Cholangiocarcinoma 1Carcinoma, Renal Cell 1

Interventions

Irinotecan 4Bevacizumab 3Oxaliplatin 2Leucovorin 2Fluorouracil 2Drug Therapy 2Cyclophosphamide 2Cetuximab 2Capecitabine 2pembrolizumab 1napabucasin 1guadecitabine 1encorafenib 1Sutures 1Surgical Instruments 1Pemetrexed 1Oviposition 1Ocoxin 1Magnetic Resonance Spectroscopy 1Levoleucovorin 1Leukocyte Immunoglobulin-like Receptor B1 1KRN-330 1Drainage 1Colonoscopy 1Chemoradiotherapy 1Aspirin 1Ascorbic Acid 15-(2,4-dihydroxy-5-isopropylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic acid ethylamide 15,10-methylenetetrahydrofolic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Rectal Diseases × guadecitabine × Gastrointestinal × Clear all
NCT01966289 2021-03-30

SGI-110 in Combination With an Allogeneic Colon Cancer Cell Vaccine (GVAX) and Cyclophosphamide (CY) in Metastatic Colorectal Cancer (mCRC)

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1 Completed
18 enrolled
Gastrointestinal

Colonic Diseases, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplasms, Neoplasms by Site, Rectal Diseases, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡